GlassScriptPhysician profile
Andrew James Luna
NPI 1821877721
$1,324.06
in general payments reported to CMS, 2019-2025
13 companies · $821 in 2025
The $821 reported for 2025 was more than what 77% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $16.67 · 2024: $487 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,324.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $290.06 | 2025 | Intracept |
| Foundation Fusion Solutions, LLC | $244.39 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $194.87 | 2023-2025 | Belbuca, Xtampza |
| Abbott Laboratories | $133.88 | 2025 | Eterna |
| Spr Therapeutics, INC | $97.84 | 2024 | Sprint Pns System |
| Vertos Medical, INC. | $94.01 | 2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $89.32 | 2025 | Evoke |
| Spinal Simplicity, LLC | $45.70 | 2025 | Ha Minuteman G3-R |
| Virtus Pharmaceuticals LLC | $40.34 | 2024 | Levorphanol Tartrate |
| Valinor Pharma, LLC | $34.99 | 2024 | Movantik |
| International Rehabilitative Sciences, INC | $29.48 | 2024-2025 | Rs 4i Plus Sequential Stimulator |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.20 | 2025 | Relistor |
| Electronic Waveform Lab, INC. | $4.98 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Luna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.